
Earlier this month the United States Food and Drug Administration (FDA) issued a recall statement on Ranitidine tablets after unacceptable levels of N-Nitrosodimethylamine (NDMA) were found in the tablets. Ranitidine tablets are commonly sold under the brand names of Zantac or Wal-Zan. NDMA has been identified as a probable human carcinogen by the World Health …